Spiropiperidine compounds as ORL-1 receptor antagonists

Details for Australian Patent Application No. 2010319400 (hide)

Owner Eli Lilly and Company

Inventors Benito Collado, Ana Belen; Diaz Buezo, Nuria; Jimenez-Aguado, Alma Maria; Lafuente Blanco, Celia; Martinez-Grau, Maria Angeles; Pedregal-Tercero, Concepcion; Toledo Escribano, Miguel Angel

Agent Spruson & Ferguson

Pub. Number AU-A-2010319400

PCT Pub. Number WO2011/060217

Priority 09382245.0 16.11.09 EP; 61/298,628 27.01.10 US

Filing date 12 November 2010

Wipo publication date 19 May 2011

International Classifications

C07D 495/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/060217 Priority application(s): WO2011/060217

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319403-Systems and methods for combined physiological sensors

2010319398-Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer